CLINICAL_TRIALS
research
· 2025-01-14
Clinical Trial Update: Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM) [NA]
Summary
An ongoing Yale University clinical trial is investigating whether reversibility of brain glucose transport can be achieved in individuals with Type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yale University | Conditions: Diabetes Mellitus, Type 2 | NA | Status: RECRUITING